STEVE PHILLIPS
Directeur/Membre du Conseil chez Wellth, Inc.
Profil
Steve Phillips
Group Vice President, Strategy and Innovation
Steve is the business lead for DaVita Venture Group and has responsibility for managing the portfolio of DaVita’s innovation efforts and investments.
He has focused his career on health care strategy and has experience driving growth and innovation within large health plans and providers.
Prior to joining DaVita Venture Group, he focused on DaVita’s enterprise strategy to lead the transformation of kidney care and developed new sources of growth.
Before joining DaVita, Steve was a health care strategy consultant.
He has an undergraduate degree from Lafayette College and an MBA from the University of Virginia’s Darden School of Business.
Postes actifs de STEVE PHILLIPS
| Sociétés | Poste | Début |
|---|---|---|
Davita Venture Group
 Davita Venture Group Investment ManagersFinance DaVita Venture Group (DaVita Venture Group) is a venture capital firm subsidiary of DaVita Inc. founded in 2019. The firm is headquartered in Denver, Colorado. | Private Equity Investor | 01/10/2015 |
Wellth, Inc.
 Wellth, Inc. Internet Software/ServicesTechnology Services Wellth, Inc., provides mobile application for insurers and risk-bearing healthcare providers. The company was founded by Matt Loper and Alec Zopf in 2014 and is headquartered in New York, NY. | Directeur/Membre du Conseil | 01/05/2020 |
Nephrosant, Inc.
 Nephrosant, Inc. BiotechnologyHealth Technology Nephrosant, Inc. is a company dedicated to improving kidney health through noninvasive diagnostic tests. The company is based in Brisbane, CA. The company's flagship diagnostic test is QSant, a noninvasive urine-based test that supports early detection of kidney rejection risk. Nephrosant plans to develop centralized lab tests and point of care tests for kidney diseases and allograft monitoring for other organs. Founded in 2017 by Dr. Minnie Sarwal and UCSF physicians, the company has a team of world-class scientists, engineers, and clinicians who have licensed the founding team's clinical research to develop diagnostic tests for chronic kidney disease. Dr. Sarwal has been the CEO since 2017. | Consultant / Advisor | 01/11/2020 |
Anciens postes connus de STEVE PHILLIPS
| Sociétés | Poste | Fin |
|---|---|---|
| Convergehealth | Private Equity Investor | 01/09/2015 |
Formation de STEVE PHILLIPS
| University of Virginia Darden School of Business | Masters Business Admin |
| Lafayette College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Davita Venture Group
Davita Venture Group Investment ManagersFinance DaVita Venture Group (DaVita Venture Group) is a venture capital firm subsidiary of DaVita Inc. founded in 2019. The firm is headquartered in Denver, Colorado. | Finance |
| Convergehealth | |
Wellth, Inc.
Wellth, Inc. Internet Software/ServicesTechnology Services Wellth, Inc., provides mobile application for insurers and risk-bearing healthcare providers. The company was founded by Matt Loper and Alec Zopf in 2014 and is headquartered in New York, NY. | Technology Services |
Nephrosant, Inc.
Nephrosant, Inc. BiotechnologyHealth Technology Nephrosant, Inc. is a company dedicated to improving kidney health through noninvasive diagnostic tests. The company is based in Brisbane, CA. The company's flagship diagnostic test is QSant, a noninvasive urine-based test that supports early detection of kidney rejection risk. Nephrosant plans to develop centralized lab tests and point of care tests for kidney diseases and allograft monitoring for other organs. Founded in 2017 by Dr. Minnie Sarwal and UCSF physicians, the company has a team of world-class scientists, engineers, and clinicians who have licensed the founding team's clinical research to develop diagnostic tests for chronic kidney disease. Dr. Sarwal has been the CEO since 2017. | Health Technology |
